itmn

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Shares of WellCare Health Plans Rise to ...

Shares of WellCare Health Plans (NYSE:WCG) traded at a new 52-week high today of $90.58 ...

Watch for Continued Gains in Shares of V...

VeriSign (NASDAQ:VRSN) traded at a new 52-week high today of $64.95. Approximately 538 ...

Shares of Vulcan Materials Have Risen Ab...

Vulcan Materials (NYSE:VMC) traded at a new 52-week high today of $83.49. This new hig ...

Shares of Universal Insurance Holdings R...

Shares of Universal Insurance Holdings (AMEX:UVE) traded at a new 52-week high today of ...

UIL Holdings Looks to Continue to Trade ...

UIL Holdings (NYSE:UIL) traded at a new 52-week high today of $51.67. This new high wa ...

Texas Instruments Looks to Continue to T...

Shares of Texas Instruments (NYSE:TXN) traded at a new 52-week high today of $59.37. A ...

Shares of Total System Services Rise to ...

Total System Services (NYSE:TSS) traded today at a new 52-week high of $38.45. Approxi ...

Watch for Continued Gains in Shares of T...

Shares of TeleNav (NASDAQ:TNAV) traded at a new 52-week high today of $8.71. Approxima ...

Most Popular Video News